Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ºñ±Í±Ý¼ÓÇÕ±Ý Ç¥¸é󸮹æ¹ý°ú ·¹Áø½Ã¸àÆ® Á¾·ù°¡ Á¢ÂøÀÎÀå°­µµ¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ °üÇÑ ¿¬±¸

A study of tensile bond strength according to varied treatment methods of nonrecious metal sufrace and resin cements

´ëÇÑÄ¡°úº¸Ã¶ÇÐȸÁö 1996³â 34±Ç 2È£ p.335 ~ 348
¾çÅÂÁø, ÀÓÁÖȯ, Á¶ÀÎÈ£,
¼Ò¼Ó »ó¼¼Á¤º¸
¾çÅÂÁø ( Yang Tae-Jin ) - ´Ü±¹´ëÇб³ Ä¡°ú´ëÇÐ Ä¡°úº¸Ã¶Çб³½Ç
ÀÓÁÖȯ ( Lim Ju-Hwan ) - ´Ü±¹´ëÇб³ Ä¡°ú´ëÇÐ Ä¡°úº¸Ã¶Çб³½Ç
Á¶ÀÎÈ£ ( Cho In-Ho ) - ´Ü±¹´ëÇб³ Ä¡°ú´ëÇÐ Ä¡°úº¸Ã¶Çб³½Ç

Abstract


Retention is one of the major factors deciding the success and longevity of resin bonded restorations. The purpose of this study was to find a better resin cement and metal surface treatment method that would enhance the bonding strength. The bonding surfaces of Verabond, one of Ni-Cr-Be alloys, were treated with sandblasting (Group 1), sandblasting and EZ-Oxisor(Group 2), sandblasting and silicoating(Group 3), and than thay were bonded with All-Bond C & B, Panavia 21 and Superbond C & B. The specimens were thermocycled, and the tensile bond strength was measured using the universal testing machine. Also the mode of bond failure was observed. @ES The results were as follows. @EN 1. The Superbond C & B showed the highest bond strength among the three resin cements and decreased in the order of Panavia 21, All Bond C & B. There was significant difference among them(p<0.05). 2. Group 3 showed the highest bond strength among the three metal surface treatment methods, and there was significant difference compared with Group 1 and Group 2(p<0.05). But there was no significant difference between Group 1 and Group 2. 3. Observing the mode of bond failure, Superbond C & B and panavia 21 showed mostly cohesive failure in all groups. All-Bond C & B showed all types of bond failure in Ground 3, but Group 1 and Group 2 showed only adhesive failure. 4. According to the results of this study, the silicoating method and 4-META containing resin cement were considered to be more acceptable for resin bonded restoration

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed